Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)

NCT06621888 is registered in ClinicalTrials.gov with Fenix Innovation Group as lead sponsor.

NCT NCT06621888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06621888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)
Lead sponsor
Fenix Innovation Group
Phase
Phase 1/2
Overall status
Completed
Start date
June 2, 2023
Completion date
December 1, 2025
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pans pediatric acute-onset neuropsychiatric syndrome